Artelo Biosciences, Inc. (ARTL)
5.85
-0.13
(-2.17%)
USD |
NASDAQ |
Sep 10, 14:17
Artelo Biosciences Total Liabilities (Quarterly) : 1.462M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.462M |
| March 31, 2026 | 5.846M |
| December 31, 2025 | 4.073M |
| September 30, 2025 | 4.90M |
| June 30, 2025 | 5.763M |
| March 31, 2025 | 2.863M |
| December 31, 2024 | 1.841M |
| September 30, 2024 | 0.775M |
| June 30, 2024 | 1.027M |
| March 31, 2024 | 0.817M |
| December 31, 2023 | 1.291M |
| September 30, 2023 | 0.921M |
| June 30, 2023 | 0.609M |
| March 31, 2023 | 0.84M |
| December 31, 2022 | 1.021M |
| September 30, 2022 | 0.512M |
| June 30, 2022 | 0.567M |
| March 31, 2022 | 0.924M |
| August 31, 2021 | 0.593M |
| Date | Value |
|---|---|
| May 31, 2021 | 0.4239M |
| February 28, 2021 | 0.589M |
| November 30, 2020 | 0.4856M |
| August 31, 2020 | 0.5022M |
| May 31, 2020 | 0.2685M |
| February 29, 2020 | 0.444M |
| November 30, 2019 | 0.5846M |
| August 31, 2019 | 1.022M |
| May 31, 2019 | 1.019M |
| February 28, 2019 | 1.176M |
| November 30, 2018 | 0.6405M |
| August 31, 2018 | 0.532M |
| May 31, 2018 | 0.4923M |
| February 28, 2018 | 0.1558M |
| November 30, 2017 | 0.1363M |
| August 31, 2017 | 0.0294M |
| May 31, 2017 | 0.3418M |
| February 28, 2017 | 0.0329M |
| November 30, 2016 | 0.01M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.459M |
| Shareholders Equity (Quarterly) | 4.997M |
| Debt to Equity Ratio | 0.0098 |
| Current Ratio | 3.004 |
| Net Debt Paydown Yield | 0.02% |